Rory J. Flinn, Ph.D. - Publications

Affiliations: 
2011 Yeshiva University, New York, NY, United States 
Area:
Cell Biology, Biochemistry

7 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2012 Smirnova T, Zhou ZN, Flinn RJ, Wyckoff J, Boimel PJ, Pozzuto M, Coniglio SJ, Backer JM, Bresnick AR, Condeelis JS, Hynes NE, Segall JE. Phosphoinositide 3-kinase signaling is critical for ErbB3-driven breast cancer cell motility and metastasis. Oncogene. 31: 706-15. PMID 21725367 DOI: 10.1038/Onc.2011.275  0.611
2010 Flinn RJ, Backer JM. mTORC1 signals from late endosomes: taking a TOR of the endocytic system. Cell Cycle (Georgetown, Tex.). 9: 1869-70. PMID 20436274 DOI: 10.4161/Cc.9.10.11679  0.592
2010 Flinn RJ, Yan Y, Goswami S, Parker PJ, Backer JM. The late endosome is essential for mTORC1 signaling. Molecular Biology of the Cell. 21: 833-41. PMID 20053679 DOI: 10.1091/Mbc.E09-09-0756  0.59
2009 Wu H, Shekar SC, Flinn RJ, El-Sibai M, Jaiswal BS, Sen KI, Janakiraman V, Seshagiri S, Gerfen GJ, Girvin ME, Backer JM. Regulation of Class IA PI 3-kinases: C2 domain-iSH2 domain contacts inhibit p85/p110alpha and are disrupted in oncogenic p85 mutants. Proceedings of the National Academy of Sciences of the United States of America. 106: 20258-63. PMID 19915146 DOI: 10.1073/Pnas.0902369106  0.566
2009 Pang H, Flinn R, Patsialou A, Wyckoff J, Roussos ET, Wu H, Pozzuto M, Goswami S, Condeelis JS, Bresnick AR, Segall JE, Backer JM. Differential enhancement of breast cancer cell motility and metastasis by helical and kinase domain mutations of class IA phosphoinositide 3-kinase. Cancer Research. 69: 8868-76. PMID 19903845 DOI: 10.1158/0008-5472.Can-09-1968  0.613
2009 Yan Y, Flinn RJ, Wu H, Schnur RS, Backer JM. hVps15, but not Ca2+/CaM, is required for the activity and regulation of hVps34 in mammalian cells. The Biochemical Journal. 417: 747-55. PMID 18957027 DOI: 10.1042/Bj20081865  0.562
2007 El-Sibai M, Nalbant P, Pang H, Flinn RJ, Sarmiento C, Macaluso F, Cammer M, Condeelis JS, Hahn KM, Backer JM. Cdc42 is required for EGF-stimulated protrusion and motility in MTLn3 carcinoma cells. Journal of Cell Science. 120: 3465-74. PMID 17855387 DOI: 10.1242/Jcs.005942  0.58
Show low-probability matches.